|
||||||
 |
||||||
Dockets
Management
|
||||||
|
Food and Drug Administration CENTER FOR DRUG EVALUATION AND RESEARCH
(CDER) Cardiovascular and Renal Drugs Advisory
Committee Hilton SLIDES 1:00
P.M. – 5:00 P.M. The
committee will discuss the safety implications for the use
of placebo in studies of drugs to treat antihypertension.
The largest database is from the “Placebo in Hypertension
Adverse Reaction Meta-Analysis” (PHARM) Study, a meta-analysis
of more than 80,000 patients in placebo-controlled trials
of antihypertensive medication submitted in NDAs FDA Presentation
Page last updated
May 9, 2006
kk |
